This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Reckitt Benckiser (continuing ops) Q4 net revenues +2% (+4% at constant FX & like-for-like beats +3.3% est). FY +10% (+15% at constant FX, top of guidance; +3% like-for-like). Q4 Infant +5% like-for like misses 6.6% est; Rest of Health +3% like-for-like beats 2.1% est, Total Health +4% beats 3.7% est; Hygiene & Home +4% beats 3% est; Adj. op profit +8% (+12% at constant FX). Net income +7%/+11%; final div +3%; Targets 3-4% net rev growth in 2019, adj. op margin maintained.
Barclays shares may be sensitive to an FT report that US hedge fund Tiger Global has sold down its entire 2.5% stake.
UK Housebuilders may react favourably to a rise in UK Rightmove House Price growth accelerating Feb (0.7% vs 0.4% prev.), although annual growth slowed further (0.2% vs 0.4% prev).
Petra Diamonds H1 production +9.5% YoY, revenue +7.9%, adj. EBITDA -6.4%, after lower value Cullinan product mix. Net debt +7.4%, capex -41.5%. FY production guidance unchanged. Expects FY net debt unchanged. Appoints Richard Duffy (ex-Anglo American/AngloGold Ashanti) new CEO.
McColl’s Retail FY like-for-like sales -1.4% YoY (Q4 flat) due to supply chain disruption following Palmer & Harvey’s entry into administration, pre-tax profit -57%. FY dividend -61%. Early 2019 trading improved (Q1’19 +1.2% YTD).
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ROYAL BANK OF SCOTLAND | RBS | 2.1% | 2.9% | -1.6% |
| MONDI | MNDI | 0.9% | 3.1% | 0.1% |
| SEGRO | SGRO | -0.7% | 2.3% | -0.9% |
| CENTAMIN | CEY | 3.0% | 6.1% | 1.6% |
| MILLENNIUM & COPTHORNE HOTEL | MLC | -2.0% | -1.9% | -3.1% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research